Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
4.940
-0.130 (-2.56%)
At close: Apr 1, 2025, 4:00 PM
4.930
-0.010 (-0.20%)
After-hours: Apr 1, 2025, 6:43 PM EDT
Cara Therapeutics Employees
Cara Therapeutics had 10 employees as of December 31, 2024. The number of employees decreased by 45 or -81.82% compared to the previous year.
Employees
10
Change (1Y)
-45
Growth (1Y)
-81.82%
Revenue / Employee
$713,700
Profits / Employee
-$7,086,700
Market Cap
22.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CARA News
- 5 weeks ago - CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA - Business Wire
- 3 months ago - Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split - GlobeNewsWire
- 3 months ago - Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement - GlobeNewsWire
- 10 months ago - These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers' - Benzinga
- 10 months ago - Cara Therapeutics discontinues study on a neurological condition as drug fails - Reuters
- 10 months ago - Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica - GlobeNewsWire
- 11 months ago - Cara Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 11 months ago - Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 - GlobeNewsWire